Dr. James M. Mobley, M.D.
Hematology & Oncology (Hematology & Oncology Physician)
- Medicare participating
At a glance
- Medical school
- Texas A & M University System, Hsc, College of Medicine (2015)
- Years since graduation
- 11
- In the NPI registry since
- 2015
- Medicare patients seen, 2024
- 619
Licensed in Texas since 2021, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2015Medical school: Texas A & M University System, Hsc, College of Medicine
- 2015Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
TX license T3827 (first issued 2021; active) · KY license 52720 -
Internal Medicine Physician
TX license T3827 (first issued 2021; active) -
Medical Oncology Physician
TX license T3827 (first issued 2021; active) - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Baylor Scott & White Medical Center Plano Plano, TX
- Baylor Scott & White the Heart Hospital Plano Plano, TX
- Baylor Scott & White Medical Center - Centennial Frisco, TX
- Baylor Scott and White Medical Center Frisco at Pg Frisco, TX
Medical groups
- Texas Oncology PA (1,014 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 619
- Services billed
- 163,244
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 30,600 | 44 |
| Injection, oxaliplatin, 0.5 mg | 14,360 | 13 |
| Injection, pembrolizumab, 1 mg | 10,000 | 19 |
| Injection, iron sucrose, 1 mg | 7,200 | 20 |
| Injection, paclitaxel, 1 mg | 5,336 | 12 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 4,695 | 51 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 3,720 | 14 |
| Injection, bortezomib, 0.1 mg | 3,570 | 15 |
| Injection, dexamethasone sodium phosphate, 1 mg | 2,673 | 81 |
| Injection, granisetron hydrochloride, 100 mcg | 1,040 | 26 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Anastrozole Other prescribers in Plano, TX | 187 |
| Potassium Chloride Other prescribers in Plano, TX | 55 |
| Dexamethasone Other prescribers in Plano, TX | 50 |
| Prednisone Other prescribers in Plano, TX | 42 |
| Prochlorperazine Maleate Other prescribers in Plano, TX | 37 |
| Eliquis (apixaban) Other prescribers in Plano, TX | 32 |
| Gabapentin Other prescribers in Plano, TX | 26 |
| Ondansetron Odt (ondansetron) Other prescribers in Plano, TX | 23 |
| Xarelto (rivaroxaban) Other prescribers in Plano, TX | 20 |
| Acyclovir Other prescribers in Plano, TX | 19 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 21 companies reported 58 payments worth $1,171 in total to this clinician.
| Novartis Pharmaceuticals Corporation | $168 |
|---|---|
| Janssen Biotech, Inc. | $125 |
| Merck Sharp & Dohme LLC | $119 |
| Gilead Sciences, Inc. | $84.89 |
| E.r. Squibb & Sons, L.l.c. | $83.16 |
| Array Biopharma Inc | $77.33 |
| Jazz Pharmaceuticals Inc. | $75.45 |
| Pfizer Inc. | $65.55 |
| Food and Beverage | $1,171 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.